Efficacy and safety of intravesical instillation of KRP‐116D (50% dimethyl sulfoxide solution) for interstitial cystitis/bladder pain syndrome in Japanese patients: A multicenter, randomized, double‐blind, placebo‐controlled, clinical study

To evaluate the efficacy and safety of intravesical KRP‐116D, 50% dimethyl sulfoxide solution compared with placebo, in interstitial cystitis/bladder pain syndrome patients.

[1]  R. Dmochowski,et al.  Targeting the SHIP1 Pathway Fails to Show Treatment Benefit in Interstitial Cystitis/Bladder Pain Syndrome: Lessons Learned from Evaluating Potentially Effective Therapies in This Enigmatic Syndrome. , 2019, The Journal of urology.

[2]  P. Hanno,et al.  Phenotyping of interstitial cystitis/bladder pain syndrome , 2019, International journal of urology : official journal of the Japanese Urological Association.

[3]  M. Fall,et al.  Hunner lesion versus non‐Hunner lesion interstitial cystitis/bladder pain syndrome , 2019, International journal of urology : official journal of the Japanese Urological Association.

[4]  Y. Homma.  Interstitial cystitis, bladder pain syndrome, hypersensitive bladder, and interstitial cystitis/bladder pain syndrome – clarification of definitions and relationships , 2019, International journal of urology : official journal of the Japanese Urological Association.

[5]  J. Nickel,et al.  FDA BRUDAC 2018 Criteria for Interstitial Cystitis/Bladder Pain Syndrome Clinical Trials: Future Direction for Research. , 2018, The Journal of urology.

[6]  C. Nickel,et al.  TREATMENT EFFECTIVENESS IN INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME: DO PATIENT PERCEPTIONS ALIGN WITH EFFICACY BASED GUIDELINES?: MP29‐20 , 2017, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

[7]  E. Rovner,et al.  Dimethyl sulfoxide (DMSO) as intravesical therapy for interstitial cystitis/bladder pain syndrome: A review , 2017, Neurourology and urodynamics.

[8]  S. Vitale,et al.  Etiology, pathophysiology and biomarkers of interstitial cystitis/painful bladder syndrome , 2017, Archives of Gynecology and Obstetrics.

[9]  J. Thipphawong,et al.  Fulranumab in patients with interstitial cystitis/bladder pain syndrome: observations from a randomized, double-blind, placebo-controlled study , 2017, BMC Urology.

[10]  C. Kelleher,et al.  A Narrative Review of Patient-reported Outcomes in Overactive Bladder: What is the Way of the Future? , 2016, European urology.

[11]  P. Hanno,et al.  The Role of Glomerulations in Bladder Pain Syndrome: A Review. , 2016, The Journal of urology.

[12]  H. Tomoe.  In what type of interstitial cystitis/bladder pain syndrome is DMSO intravesical instillation therapy effective? , 2014, Translational andrology and urology.

[13]  J. Nickel,et al.  Efficacy of intravesical chondroitin sulphate in treatment of interstitial cystitis/bladder pain syndrome (IC/BPS): Individual patient data (IPD) meta-analytical approach. , 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

[14]  A. Lindner,et al.  Predictors of response to intravesical dimethyl-sulfoxide cocktail in patients with interstitial cystitis. , 2012, Urology.

[15]  R. Dmochowski,et al.  Contemporary management of the painful bladder: a systematic review. , 2012, European urology.

[16]  Ursula Wesselmann,et al.  AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. , 2011, The Journal of urology.

[17]  Y. Homma,et al.  Japanese guideline for diagnosis and treatment of interstitial cystitis , 2009, International journal of urology : official journal of the Japanese Urological Association.

[18]  M. Fall,et al.  Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. , 2008, European urology.

[19]  T. Dawson,et al.  Intravesical treatments for painful bladder syndrome/ interstitial cystitis. , 2007, The Cochrane database of systematic reviews.

[20]  E. Messing,et al.  A randomized controlled trial of intravesical bacillus calmette-guerin for treatment refractory interstitial cystitis. , 2005, The Journal of urology.

[21]  G. Sant,et al.  Intravesical dimethyl sulfoxide (DMSO) for interstitial cystitis--a practical approach. , 1998, Urology.

[22]  R. Perez-Marrero,et al.  A controlled study of dimethyl sulfoxide in interstitial cystitis. , 1988, The Journal of urology.

[23]  C. Garcia,et al.  OCULAR TOXICOLOGY OF DIMETHYL SULFOXIDE AND EFFECTS ON RETINITIS PIGMENTOSA , 1983, Annals of the New York Academy of Sciences.

[24]  L. Frödin,et al.  The use of dimethyl-sulfoxide (DMSO) in the treatment of interstitial cystitis. , 1978, Scandinavian journal of urology and nephrology.

[25]  D. Wood,et al.  PHARMACOLOGIC AND BIOCHEMICAL CONSIDERATIONS OF DIMETHYL SULFOXIDE , 1975, Annals of the New York Academy of Sciences.